What is ALXYD's earnings per share (EPS)?

ALXYD (ALXYD) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

ALXYD Financials

ALXYD

Source SEC Filings (10-K/10-Q) Updated Nov 30, 2025 Currency USD FYE February

This page shows ALXYD (ALXYD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 25/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Growth

100

ALXYD's revenue surged 75.5% year-over-year to $38K, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage

ALXYD has elevated debt relative to equity (D/E of 20.57), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

ALXYD's current ratio of 0.37 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 2/100, which could limit financial flexibility.

Returns

ALXYD generates a -419.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -24.1% the prior year.

Piotroski F-Score Neutral

4/9

ALXYD passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-1.04x

For every $1 of reported earnings, ALXYD generates $-1.04 in operating cash flow ($24K OCF vs -$23K net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$38K

YoY+75.5%

ALXYD generated $38K in revenue in fiscal year 2025. This represents an increase of 75.5% from the prior year.

EBITDA

N/A

Net Income

-$23K

YoY-234.6%

ALXYD reported -$23K in net income in fiscal year 2025. This represents a decrease of 234.6% from the prior year.

EPS (Diluted)

$0.00

ALXYD earned $0.00 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$14K

YoY+52.8%

ALXYD held $14K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY+0.0%

ALXYD had 7M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

100.0%

YoY+0.0pp

ALXYD's gross margin was 100.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.0 percentage points from the prior year.

Operating Margin

N/A

Net Margin

-60.0%

YoY-28.5pp

ALXYD's net profit margin was -60.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 28.5 percentage points from the prior year.

Return on Equity

-419.6%

YoY-395.5pp

ALXYD's ROE was -419.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 395.5 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

ALXYD Income Statement

Metric	FY25	FY24	FY23
Revenue	$38K+75.5%	$22K	N/A
Cost of Revenue	$38K+75.5%	$22K	N/A
Gross Profit	$38K+75.5%	$22K	N/A
R&D Expenses	N/A	N/A	N/A
SG&A Expenses	$60K+120.3%	$27K+1943.4%	$1K
Operating Income	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A
Income Tax	$0	N/A	N/A
Net Income	-$23K-234.6%	-$7K-404.5%	-$1K
EPS (Diluted)	$0.00	$0.00+100.0%	$-0.01

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	$1K-95.5%	$24K+113.1%	$11K-19.9%	$14K+62.1%	$9K-16.7%	$11K+167.1%	$4K+20.7%	$3K
Cost of Revenue	$0	$0-100.0%	$11K-66.0%	$34K	$0	$0-100.0%	$4K+20.7%	$3K
Gross Profit	$1K-95.5%	$24K+113.1%	$11K+159.0%	-$19K-320.0%	$9K-16.7%	$11K+167.1%	$4K+20.7%	$3K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$4K-75.9%	$16K-63.3%	$43K+188.2%	$15K+63.2%	$9K-54.4%	$20K+23.2%	$16K+421.1%	$3K
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$0	$0	N/A	N/A	$0	$0	N/A	N/A
Net Income	-$3K-129.0%	$9K+127.5%	-$32K-5270.7%	-$587-93.7%	-$303+96.8%	-$9K+23.2%	-$12K-1658.9%	-$700
EPS (Diluted)	$0.00	$0.00	$0.00	N/A	$0.00	$0.00	$0.00	N/A

ALXYD Balance Sheet

Metric	FY25	FY24	FY23
Total Assets	$116K+7.8%	$108K+119.9%	$49K
Current Assets	$41K-51.3%	$85K+484.9%	$15K
Cash & Equivalents	$14K+52.8%	$9K+20.8%	$8K
Inventory	N/A	N/A	N/A
Accounts Receivable	N/A	$15K	N/A
Goodwill	N/A	N/A	N/A
Total Liabilities	$111K+38.8%	$80K+65.9%	$48K
Current Liabilities	$111K+38.8%	$80K+65.9%	$48K
Long-Term Debt	N/A	N/A	N/A
Total Equity	$5K-80.8%	$28K+2920.2%	$929
Retained Earnings	-$34K-209.0%	-$11K-166.3%	-$4K

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$98K-3.6%	$102K-13.4%	$117K+0.8%	$116K+22.0%	$95K-4.4%	$100K+22.6%	$81K-24.6%	$108K
Current Assets	$4K-33.3%	$6K-71.4%	$20K-52.4%	$41K+24.4%	$33K-9.0%	$37K+9.7%	$33K-60.8%	$85K
Cash & Equivalents	$0	$0-100.0%	$17K+20.3%	$14K+1020.5%	$1K+3648.5%	$33-82.8%	$192-97.9%	$9K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$15K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$622-63.9%	$2K-98.8%	$144K+29.3%	$111K+24.1%	$89K-4.4%	$94K+42.4%	$66K-17.9%	$80K
Current Liabilities	$622-63.9%	$2K-98.8%	$144K+29.3%	$111K+24.1%	$89K-4.4%	$94K+42.4%	$66K-17.9%	$80K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$97K-2.5%	$100K+482.5%	-$26K-583.8%	$5K-9.8%	$6K-4.8%	$6K-60.1%	$16K-43.9%	$28K
Retained Earnings	-$59K-4.5%	-$56K+13.3%	-$65K-94.1%	-$34K-1.8%	-$33K-0.9%	-$33K-40.8%	-$23K-113.6%	-$11K

ALXYD Cash Flow Statement

Metric	FY25	FY24	FY23
Operating Cash Flow	$24K+137.7%	-$62K-363.1%	$24K
Capital Expenditures	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A
Investing Cash Flow	-$55K-654.0%	$10K+128.7%	-$35K
Financing Cash Flow	$37K-31.9%	$54K+228.9%	$16K
Dividends Paid	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	-$622+98.9%	-$55K-365.6%	$21K-22.4%	$27K+279.9%	-$15K-193.6%	$16K+482.8%	-$4K+90.3%	-$43K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$0	$0+100.0%	-$24K-71.4%	-$14K	$0+100.0%	-$16K+37.0%	-$25K-249.4%	$17K
Financing Cash Flow	$622-98.4%	$38K+520.8%	$6K	$0-100.0%	$16K+44344.4%	$36-99.8%	$21K-38.2%	$33K
Dividends Paid	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ALXYD Financial Ratios

Metric	FY25	FY24	FY23
Gross Margin	100.0%0.0pp	100.0%	N/A
Operating Margin	N/A	N/A	N/A
Net Margin	-60.0%-28.5pp	-31.5%	N/A
Return on Equity	-419.6%-395.5pp	-24.1%+120.3pp	-144.5%
Return on Assets	-19.4%-13.2pp	-6.3%-3.5pp	-2.7%
Current Ratio	0.37-0.7	1.06+0.8	0.30
Debt-to-Equity	20.57+17.7	2.85-49.0	51.89
FCF Margin	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	100.0%0.0pp	100.0%0.0pp	100.0%+235.7pp	-135.7%-235.7pp	100.0%0.0pp	100.0%0.0pp	100.0%0.0pp	100.0%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-228.4%-263.8pp	35.4%+310.1pp	-274.7%-270.6pp	-4.1%-0.7pp	-3.4%+85.7pp	-89.1%+220.8pp	-310.0%-288.7pp	-21.3%
Return on Equity	-2.6%-11.3pp	8.7%	N/A	-10.9%-5.8pp	-5.1%+145.3pp	-150.3%-72.1pp	-78.2%-75.7pp	-2.5%
Return on Assets	-2.6%-11.1pp	8.5%+35.4pp	-26.8%-26.3pp	-0.5%-0.2pp	-0.3%+9.2pp	-9.5%+5.6pp	-15.1%-14.5pp	-0.7%
Current Ratio	6.03+2.8	3.27+3.1	0.14-0.2	0.370.0	0.37-0.0	0.39-0.1	0.51-0.6	1.06
Debt-to-Equity	0.01-0.0	0.02+5.5	-5.50-26.1	20.57+5.6	14.95+0.1	14.88+10.7	4.17+1.3	2.85
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: The current ratio is below 1.0 (0.37), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is ALXYD's annual revenue?

ALXYD (ALXYD) reported $38K in total revenue for fiscal year 2025. This represents a 75.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is ALXYD's revenue growing?

ALXYD (ALXYD) revenue grew by 75.5% year-over-year, from $22K to $38K in fiscal year 2025.

Is ALXYD profitable?

No, ALXYD (ALXYD) reported a net income of -$23K in fiscal year 2025, with a net profit margin of -60.0%.

What is ALXYD's gross margin?

ALXYD (ALXYD) had a gross margin of 100.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is ALXYD's net profit margin?

ALXYD (ALXYD) had a net profit margin of -60.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is ALXYD's return on equity (ROE)?

ALXYD (ALXYD) has a return on equity of -419.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is ALXYD's operating cash flow?

ALXYD (ALXYD) generated $24K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are ALXYD's total assets?

ALXYD (ALXYD) had $116K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does ALXYD have outstanding?

ALXYD (ALXYD) had 7M shares outstanding as of fiscal year 2025.

What is ALXYD's current ratio?

ALXYD (ALXYD) had a current ratio of 0.37 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is ALXYD's debt-to-equity ratio?

ALXYD (ALXYD) had a debt-to-equity ratio of 20.57 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is ALXYD's return on assets (ROA)?

ALXYD (ALXYD) had a return on assets of -19.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is ALXYD's Piotroski F-Score?

ALXYD (ALXYD) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are ALXYD's earnings high quality?

ALXYD (ALXYD) has an earnings quality ratio of -1.04x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is ALXYD?

ALXYD (ALXYD) scores 25 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.